Anti-Cytotoxic T Lymphocyte Antigen-4 (CTLA 4) Probody BMS-986249 +- Nivolumab (NIVO) in Patients (pts) With Advanced Cancers: Updated Phase 1 Results
BMS-986249;Nivolumab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Anti-Cytotoxic T Lymphocyte Antigen-4 (CTLA 4) Probody BMS-986249 +- Nivolumab (NIVO) in Patients (pts) With Advanced Cancers: Updated Phase 1 Results ### Output: BMS-986249;Nivolumab